Jula Inrig serves as Executive at Travere Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Jula Inrig has executed 19 insider transactions totaling $1.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 3, 2026 involved selling 6,956 shares valued at $223.4K.
Jula Inrig currently holds 107,485 shares of Travere Therapeutics, Inc. (TVTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jula Inrig has been a net seller of TVTX stock. They have purchased $0 and sold $1.1M worth of shares.
Jula Inrig's most recent insider trade was on Feb 3, 2026, when they sold 6,956 shares at $32.12 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 31, 2026 | TVTX | $0 | Award | 28,130 | $N/A | Discretionary |
| Jan 6, 2026 | TVTX | $16.8K | Sale | 445 | $37.75 | Discretionary |
| Jan 5, 2026 | TVTX | $81.6K | Sale | 2,031 | $40.18 | Discretionary |
| Dec 24, 2025 | TVTX | $133.9K | Option Exercise | 15,000 | $8.93 | Discretionary |
| Dec 24, 2025 | TVTX | $630.0K | Sale | 15,000 | $42.00 | Discretionary |
| Jul 1, 2025 | TVTX | $11.9K | Sale | 815 | $14.65 | Discretionary |
| Sep 10, 2024 | TVTX | $8.9K | Sale | 684 | $12.98 | Planned |
| Sep 9, 2024 | TVTX | $25.2K | Sale | 2,191 | $11.52 | Discretionary |
| Sep 5, 2024 | TVTX | $0 | Award | 6,750 | $N/A | Discretionary |
| Feb 1, 2024 | TVTX | $18.5K | Sale | 2,174 | $8.53 | Discretionary |
| Jan 31, 2024 | TVTX | $0 | Award | 25,000 | $N/A | Discretionary |
| Jan 4, 2024 | TVTX | $4.0K | Sale | 440 | $9.17 | Discretionary |
| Jan 3, 2024 | TVTX | $19.6K | Sale | 2,069 | $9.48 | Discretionary |
| Jan 31, 2023 | TVTX | $0 | Award | 20,250 | $N/A | Discretionary |
| Jan 5, 2023 | TVTX | $9.2K | Sale | 442 | $20.75 | Discretionary |
| Jan 4, 2023 | TVTX | $42.6K | Sale | 2,051 | $20.75 | Discretionary |
| Jan 1, 2022 | TVTX | $0 | Award | 20,000 | $N/A | Discretionary |